Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Cancer Chemotherapy and Pharmacology • 2005 | View Paper
“After a 6 h exposure of HeLa cells to 0.5 μM pralatrexate , 80 % of intracellular drug was its active polyglutamate forms, predominantly the tetraglutamate, and was suppressed when cells were loaded with natural folates.”
Cancer Chemotherapy and Pharmacology • 2013 | View Paper
“ Pralatrexate , a novel antifolate chemotherapeutic agent, was rationally designed to impede folate metabolism by inhibiting dihydrofolate reductase (DHFR) and to be more efficiently internalized into tumor cells.”